BTIG analyst Lance Jessurun reaffirmed a Neutral rating on PayPal (NASDAQ:PYPL) stock, expressing caution ahead of the ...
BTIG analyst Vincent Caintic maintained a Buy rating on Atlanticus Holdings (ATLC – Research Report) yesterday and set a price target of ...
Market technician Jonathan Krinsky analyzes the shift in market leadership from technology to healthcare amid recent ...
Fintel reports that on January 28, 2025, BTIG initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a Buy ...
In a report released today, Julian Harrison from BTIG maintained a Buy rating on Cullinan Management (CGEM – Research Report), with a price ...
Stryker (NYSE:SYK – Get Free Report) had its price target raised by research analysts at Canaccord Genuity Group from $420.00 ...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the BTIG Annual MedTech, Digital Health, Life Science ...
Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...
Shares of Carisma Therapeutics, Inc. (NASDAQ:CARM – Get Free Report) have earned an average recommendation of “Hold” from the ...
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the 12th Annual BTIG MedTech, Digital Health, ...
What damage might Monday's ongoing selloff do to the technical set-up for stocks? Well, in a note published on Sunday, BTIG chartist guru Jonathan Krinsky observed that Friday's action had already sug ...